Abiopharma

News list

Mottiwala Aziz 🔴 sold 13.1K shares of Tarsus Pharmaceuticals, Inc. (TARS) at $69.42 Transaction Date: Mar 17, 2026 | Filing ID: 000007

Full text

News bot March 19, 2026, 11:04 p.m.
🔍 Mottiwala Aziz (Executive)

Company: Tarsus Pharmaceuticals, Inc. (TARS)

Report Date: 2026-03-17
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 13,056
Detailed Transactions and Holdings:
- Sold 4,286 shares of Common Stock at $69.42 per share (Direct)
  Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 70,250.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 4,330 shares of Common Stock at $68.71 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 65,920.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 4,440 shares of Common Stock at $67.0 per share (Direct)
  Date: 2026-03-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 61,480.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.